Year-end Report (.pdf)
Interim Report Q3 2019 (.pdf)
Half-year Report 2019 (.pdf)
Interim Report Q1 2019 (.pdf)
Year-end Report 2018 (.pdf)
Interim Report Q3 2018 (.pdf)
Half-year Report 2018 (.pdf)
Interim Report Q1 2018 (.pdf)
BioStock: FDA grants Cereno Scientific’s lead candidate Orphan Drug Designation
Cereno Scientific is accelerating the building of a platform of...
Cereno Scientific’s Phase II clinical trial postponed due to Covid-19
Due to the global spread of the Sars-cov-2 virus Cereno...
Cereno Scientific Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
Cereno Scientific today announced that the U.S. Food and Drug...
LSX World Congress
2020-02-04 - 2020-02-05
Subscribe for corporate news
Follow us on LinkedIn
Follow us on Twitter
We are proud supporters of World Thrombosis Day. Read more